Author: Nicole Jupe
Kratom to be classified as a Schedule I drug
The DEA announced that it will place the active materials from the kratom plant into Schedule I of the Controlled Substances Act.
Ten most dangerous jobs in America
Can you guess the 10 most dangerous jobs in America? With a greater potential for risk, keeping these workplaces drug-free is critically important.
Quest Diagnostics Approved to Use eCCF for Federally-Mandated Workforce
Benefits of eCCF include fewer data entry and legibility issues, reduced collection site flaws, less paper to manage and improved overall efficiency.
Advantages of oral fluid drug testing
Oral fluid drug testing is emerging as a popular alternative to urine drug testing and detects very recent drug usage.
Detecting drug abuse among medical professionals
Organizations can add a comprehensive drug testing program to their efforts to protect the health and safety of both patients and medical staff.
DEA report details heroin threat
A recent report by the DEA details the threat of heroin and opioid drug abuse in the United States.
Fentanyl in the news
The U.S. is experiencing a sharp increase in the abuse of fentanyl, a powerful synthetic opioid that is 50 to 100 times more potent than morphine.
Spotlight on the prescription drug epidemic
The passing of Prince is helping to bring public awareness about the prescription drug epidemic our country is facing.
Nearing eCCF approval
Quest Diagnostics is nearing final approval by NLCP to use electronic Custody and Control Form, or eCCF, for federally-regulated drug testing.
OSHA’s new rule and post-accident drug testing
Learn what employers should know about a new OSHA regulation published May 12, 2016 and its potential impact on post-accident drug testing.
